Recent News
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/8-86716_nature-journal-logo-hd-png-download.png)
‘Breaking the mold with RNA—a “RNAissance” of life science’ – npj Genomic Medicine
Apr 2024![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Pharma-BI-Logo-e1706886422257.png)
Beacon maps over 2300 lung cancer biomarkers in new global database – PBI Forum
Feb 2024![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/CEN-logo_2.png)
New day for antibody-drug conjugates – Chemical & Engineering News
May 2022![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/3d224f4e693f499ca7c631052c02d93b.jpg)
What makes a good antibody–drug conjugate? – Martin De Cecco, Daniel N. Galbraith & Lisa L. McDermottt
Feb 2021![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/6dc895970e4b48aa8d4a8ac91c3d29ee.jpg)
Beacon Targeted Therapies announces the launch of Beacon Oncolytic Viruses
Jul 2020![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/76c25ecbf97c4916b6b1429f07a1b909.png)
Cell Therapy 2.0
Jul 2020![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/f8f8b5b1b0f24b8b944ef353db1985eb.png)
Overcoming Challenges in the Development of Anticancer ADCs
Jun 2020![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/d5979500b2504d3c93d13dd41770799f.png)
Immuno-oncology cell therapies: commercial considerations and strategies for the new decade
Jun 2020![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/6dc895970e4b48aa8d4a8ac91c3d29ee.jpg)
Beacon Targeted Therapies announces the launch of Beacon Gene Therapy
May 2020![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/5fdd77ed604848c09c020636a26823e2.jpg)
Frontiers in Oncology – Perspective: Designing T-Cell Engagers With Better Therapeutic Windows
Apr 2020![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/76c25ecbf97c4916b6b1429f07a1b909.png)
Hot Topics at CAR-TCR 2020
Apr 2020![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/16b3a6f8edd144f4aae800f66faaeea7.png)
Assessment of Clinical Activity of PD-1 Checkpoint Inhibitor Combination Therapies Reported in Clinical Trials
Feb 2020![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/377cf415131548048c41d80eda4a2982.png)
TCR Therapies Summit 2020 Magazine
Feb 2020![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Screenshot-2021-04-28-170245.jpg)
Drug developers take fresh aim at ‘guided-missile’ cancer drugs
Jan 2020![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/916b00846db84903b1d0937a2348022a-scaled.jpg)
CAR-TCR Europe Summit 2020 Magazine
Jan 2020![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/4d1e327695f74c9286d5b4a9a7a189db.png)
World ADC London 2020 Magazine
Jan 2020![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/c8c4d5ef7ca74774b656cf496ee0560f.png)
Innate Killer Summit 2020 Magazine
Jan 2020![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/f82d2f51f9e94231afb5cf401ee15bcd.jpg)
From Mylotarg to Polivy: Ebbs and flows, successes and woes of ADCs
Nov 2019![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/76c25ecbf97c4916b6b1429f07a1b909.png)
Trends & Forecasts – Tenacious ADCs
Nov 2019![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/230b6db1de3741699e3a26f9d579abb0.png)
World ADC San Diego Magazine 2019
Sep 2019![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/24c629d6f9d447dbab555dcf73966fdf.png)
Biomarkers for Checkpoint Inhibition and Their Clinical Utility – Timothy James Fabisiak, B.A.
Jul 2019![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/e5437d30c5b941cc9a96a8ec0423f484.png)
Bispecific antibodies: a mechanistic review of the pipeline Aran F. Labrijn, Maarten L. Janmaat, Janice M. Reichert & Paul W. H. I. Parren
Jun 2019![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/9dc060fe64624935aca6ff3c2285d737.png)
Beacon Targeted Therapies Launches Beacon Adoptive Cell
May 2019![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/a057b885d1ba49418a0d1b06805ee1fd.png)
The Evolving Shape of the ADC Market: The Widening Application of ADCs and Manufacturing Improvements Meeting Demand – Charlie Johnson, CEO of ADC Bio, adcbio.com
Mar 2019![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/3d224f4e693f499ca7c631052c02d93b.jpg)